TerryPhilipMillerMD

PubMed

• 41 citations
  Cognitive and noncognitive symptoms in dementia patients: relationship to cortisol and dehydroepiandrosterone.
  Terry P. Miller, Joy L. Taylor, Stephanie Rogerson, Maritess Mauricio, Quinn Kennedy
  International Psychogeriatrics. 1998-03-01
• 15 citations
  Fluoxetine and visual hallucinations in dementia
  Sabiha J. Omar, David A. Robinson, Helen D. Davies, Terry P. Miller, Jared R. Tinklenberg
  Biological Psychiatry. 1995-10-15
• 3 citations
  ERYTHROCYTE SEDIMENTATION RATE IN ALZHEIMER'S DEMENTIA
  Dave Robinson, Jeffery Bucci, Howard H. Fenn, Terry Miller, Jared R. Tinklenberg
  Journal of the American Geriatrics Society. 1995-10-01

Journal Articles

• Eligibility of Japanese American and Chinese Alzheimer’s disease patients for pivotal FDA clinical trials  
  Takagi, KA, Miller, TP, Davies, HD, Yesavage, JA, Tinklenberg, JR., Alzheimer’s and Dementia, 1/1/2007
• Cognitive and Noncognitive Symptoms in Dementia Patients: Relationship to Cortisol and Dehydroepiandrosterone (DHEA)  
  Miller, T.P., Taylor, J, . Rogerson, S, Mauricio, M, Kennedy, Q., Schatzberg, A., Tinklenberg, J.R., Yesavage, J.A., Int. Psychoger., 1/1/1998
• Fluoxetine and Visual Hallucinations in Dementia  
  Omar, S.J., Robinson, D., Davies, H.D., Miller, T.P.,Tinklenberg, J.R., Biol. Psych., 1/1/1995
• An ACTH 4-9 analog (Org 2766) and cognitive performance- High dose efficacy and safety in dementia of the Alzheimer’s type  
  Miller, TP, Fong K, Tinklenberg, JR., Biol. Psych., 1/1/1993
• Selected Psychiatric Symptoms are associated with Rate of cognitive decline in patients with Alzheimer's Disease  
  Miller, T.P., Tinklenberg, J.R., Brooks, J.O., Fenn, H.H., Yesavage, J.A., Geriatric Psychiatry Neurology, 1/1/1993
• Correlates of Memory Decline: A four-year longitudinal study of older adults with memory complaints  
  Taylor, J.L., Miller, T.P., Tinklenberg, J.R., Psychology and Aging, 1/1/1992
• Progression of cognitive decline in patients with Alzheimer's disease: Differences in patients with and without extrapyramidal signs  
  Miller, T.P., Tinklenberg, J.R., Brooks, J.O., Yesavage, J.A., Alzheimer's Disease and Related Disorders, 1/1/1991
• A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics  
  Miller, T.P., Taylor, J.L., Tinklenberg, J.R., Neuropsychobiology, 1/1/1988
• Microcomputerized testing of drug effects on divided attention  
  Thornton, J.E., Taylor, J.L., Gibson, E.L., Miller, T.P., Tinklenberg, J.R., Psychopharmacology Bulletin, 1/1/1986
• Desglycinamide-9-arginine-8-vasopressin (DGAVP) in patients with dementia  
  Peabody, C.A., Pigache, R., Miller, T.P., Berger, P.A., Yesavage, J., Tinklenberg, J.R., Neurobiology of aging., 1/1/1985
• Residual effects of flurazepam and triazolam in alcoholic subjects  
  Peabody, C.A., Thiemann, S., Thompson, J.M., Miller, T.P., Taylor, J.L., Petersen, R.C., Tinklenberg, J.R., Current Therapeutic Research., 1/1/1985
• Presenile dementia associated with elevated aluminum and zinc levels  
  Miller, T.P., Davies, H., Yesavage, J.A., Tinklenberg, J.R., Clinical Gerontologist, 1/1/1984
• Join now to see all